资源匮乏环境下的耐药性监测：结核、艾滋病毒和疟疾的现行方法和考虑因素。
Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malaria.
机构信息
Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA.
出版信息
Am J Trop Med Hyg. 2011 Feb;84(2):192-9. doi: 10.4269/ajtmh.2011.10-0363.
Abstract
In resource-constrained environments, monitoring the occurrence of tuberculosis (TB), human immunodeficiency virus (HIV), or malaria resistant to the limited number of available drugs is essential for national treatment program success. Countries with limited resources and technical capacity rely on survey designs and methods that are simple and easily integrated into routine clinical activities to minimize the impact on overburdened clinics. This paper reviews the most commonly used methods for drug-resistance surveillance of TB, HIV, and malaria and discusses the strengths and limitations of these different strategies.
摘要
在资源有限的环境中，监测结核病（TB）、人类免疫缺陷病毒（HIV）或疟疾对现有有限数量药物的耐药性的发生对于国家治疗计划的成功至关重要。资源有限和技术能力有限的国家依赖于设计简单且易于纳入常规临床活动的调查设计和方法，以最大程度地减少对负担过重的诊所的影响。本文综述了用于 TB、HIV 和疟疾耐药性监测的最常用方法，并讨论了这些不同策略的优缺点。
相似文献
1
Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malaria.资源匮乏环境下的耐药性监测：结核、艾滋病毒和疟疾的现行方法和考虑因素。
Am J Trop Med Hyg. 2011 Feb;84(2):192-9. doi: 10.4269/ajtmh.2011.10-0363.
2
Drug repositioning in the treatment of malaria and TB.药物重定位在疟疾和结核病治疗中的应用。
Future Med Chem. 2011 Sep;3(11):1413-26. doi: 10.4155/fmc.11.95.
3
Drug-resistant tuberculosis treatment complicated by antiretroviral resistance in HIV coinfected patients: a report of six cases in Lesotho.耐多药结核病合并 HIV 共感染患者的抗逆转录病毒耐药性治疗：莱索托 6 例报告。
Am J Trop Med Hyg. 2013 Jul;89(1):174-7. doi: 10.4269/ajtmh.13-0046. Epub 2013 May 13.
4
Combating antimicrobial resistance in malaria, HIV and tuberculosis.抗疟疾、艾滋病毒和结核病中的抗菌药物耐药性
Nat Rev Drug Discov. 2024 Jun;23(6):461-479. doi: 10.1038/s41573-024-00933-4. Epub 2024 May 15.
5
Practical Management of HIV-Associated Anemia in Resource-Limited Settings: Prospective Observational Evaluation of a New Mozambican Guideline.资源有限环境下HIV相关贫血的实用管理：莫桑比克一项新指南的前瞻性观察评估
AIDS Res Hum Retroviruses. 2016 Jan;32(1):12-25. doi: 10.1089/AID.2015.0030. Epub 2015 Aug 19.
6
Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.博茨瓦纳人类免疫缺陷病毒对早期耐多药结核病治疗结局的影响。
Int J Tuberc Lung Dis. 2013 Mar;17(3):348-53. doi: 10.5588/ijtld.12.0100. Epub 2013 Jan 14.
7
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.洛匹那韦利托那韦与一线和二线抗结核药物在治疗耐多药结核病的 HIV 感染儿童中的药代动力学和药物相互作用。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.00420-17. Print 2018 Feb.
8
Managing multiple and extensively drug-resistant tuberculosis and HIV.应对多重耐药和广泛耐药结核病与艾滋病病毒并存的情况。
Expert Opin Pharmacother. 2007 Jun;8(8):1035-7. doi: 10.1517/14656566.8.8.1035.
9
Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria.将针对被忽视热带病的快速影响一揽子计划纳入艾滋病、结核病和疟疾防治项目。
PLoS Med. 2006 Jan;3(5):e102. doi: 10.1371/journal.pmed.0030102.
10
HIV drug resistance monitoring in resource constrained countries.资源有限国家的艾滋病毒耐药性监测
East Afr Med J. 2011 Jan;88(1):1-3.
引用本文的文献
1
Transmitted Drug Resistance in Antiretroviral Therapy-Naive Persons With Acute/Early/Primary HIV Infection: A Systematic Review and Meta-Analysis.初治急性/早期/原发性HIV感染患者抗逆转录病毒治疗中的传播耐药性：一项系统评价和荟萃分析
Front Pharmacol. 2021 Nov 24;12:718763. doi: 10.3389/fphar.2021.718763. eCollection 2021.
2
A seven-year surveillance of epidemiology of malaria reveals travel and gender are the key drivers of dispersion of drug resistant genotypes in Kenya.一项为期七年的疟疾流行病学监测显示，旅行和性别是肯尼亚耐药基因型传播的主要驱动因素。
PeerJ. 2020 Mar 12;8:e8082. doi: 10.7717/peerj.8082. eCollection 2020.
3
Molecular assays for antimalarial drug resistance surveillance: A target product profile.抗疟药耐药性监测的分子检测方法：目标产品特征描述
PLoS One. 2018 Sep 20;13(9):e0204347. doi: 10.1371/journal.pone.0204347. eCollection 2018.
4
An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.2000 年以来涉及中低收入国家的超国家抗菌药物耐药性监测网络清单。
J Antimicrob Chemother. 2018 Jul 1;73(7):1737-1749. doi: 10.1093/jac/dky026.
5
Drying anti-malarial drugs in vitro tests to outsource SYBR green assays.体外干燥抗疟药物以外包SYBR绿检测法。
Malar J. 2015 Feb 21;14:90. doi: 10.1186/s12936-015-0600-z.
6
Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.2008-2010 年喀麦隆 HIV 耐药性早期预警指标呈下降趋势：对资源匮乏环境的经验教训和挑战。
BMC Public Health. 2013 Apr 8;13:308. doi: 10.1186/1471-2458-13-308.
7
Pharmacokinetics of sequential doses of capreomycin powder for inhalation in guinea pigs.豚鼠吸入用卷曲霉素粉序贯剂量的药代动力学。
Antimicrob Agents Chemother. 2012 May;56(5):2612-8. doi: 10.1128/AAC.06145-11. Epub 2012 Feb 13.
8
Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling.新结核病例中的多药耐药性：通过批量质量保证抽样检测局部变异。
Epidemiology. 2012 Mar;23(2):293-300. doi: 10.1097/EDE.0b013e3182459455.
本文引用的文献
1
Estimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: a simulation study.仅在公共部门开展的结核病耐药性调查中的偏倚程度和方向估计：一项模拟研究。
BMC Public Health. 2010 Jun 21;10:355. doi: 10.1186/1471-2458-10-355.
2
Surveillance of transmitted HIV type 1 drug resistance in newly diagnosed hiv type 1-infected patients in Shandong Province, China.中国山东省新诊断的1型人类免疫缺陷病毒（HIV-1）感染患者中传播的HIV-1耐药性监测
AIDS Res Hum Retroviruses. 2010 Jan;26(1):99-103. doi: 10.1089/aid.2009.0184.
3
Surveillance of HIV type 1 drug resistance among naive patients from Venezuela.
AIDS Res Hum Retroviruses. 2009 Dec;25(12):1329-33. doi: 10.1089/aid.2009.0118.
4
New medicines to improve control and contribute to the eradication of malaria.用于改善疟疾控制并助力消除疟疾的新型药物。
Nat Rev Drug Discov. 2009 Nov;8(11):879-91. doi: 10.1038/nrd2972. Epub 2009 Oct 16.
5
Global resistance surveillance: ensuring antimalarial efficacy in the future.全球耐药监测：保障未来抗疟疗效。
Curr Opin Infect Dis. 2009 Dec;22(6):593-600. doi: 10.1097/QCO.0b013e328332c4a7.
6
Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV.巴西艾滋病毒耐药性监测网络：对近期诊断出艾滋病毒的个体的调查。
J Int AIDS Soc. 2009 Sep 18;12:20. doi: 10.1186/1758-2652-12-20.
7
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.2002 - 2007年抗结核药物耐药性流行病学：全球抗结核药物耐药性监测项目的最新分析
Lancet. 2009 May 30;373(9678):1861-73. doi: 10.1016/S0140-6736(09)60331-7. Epub 2009 Apr 15.
8
Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials.间日疟原虫基因分型标记物在临床试验中用于分子监测的评估。
J Infect Dis. 2009 Apr 1;199(7):1074-80. doi: 10.1086/597303.
9
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.用于监测传播的HIV-1耐药性的耐药性突变：2009年更新
PLoS One. 2009;4(3):e4724. doi: 10.1371/journal.pone.0004724. Epub 2009 Mar 6.
10
The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.世界卫生组织预防和评估艾滋病毒耐药性的全球战略。
Antivir Ther. 2008;13 Suppl 2:1-13.
Zotero 插件